First Advantage Co. (NYSE:FA) Given Average Rating of “Moderate Buy” by Analysts

Shares of First Advantage Co. (NYSE:FA) have earned a consensus recommendation of “Moderate Buy” from the six ratings firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $76.25.

A number of research analysts recently weighed in on FA shares. William Blair started coverage on First Advantage in a research note on Tuesday, April 23rd. They issued an “outperform” rating on the stock. Truist Financial cut their price objective on First Advantage from $250.00 to $249.00 and set a “buy” rating on the stock in a research note on Monday, July 22nd. Finally, Needham & Company LLC reissued a “hold” rating on shares of First Advantage in a research note on Monday, May 13th.

First Advantage Trading Up 0.1 %

Shares of NYSE FA opened at $18.06 on Wednesday. The firm has a market capitalization of $2.62 billion, a PE ratio of 82.09, a PEG ratio of 3.27 and a beta of 1.14. The company has a current ratio of 4.29, a quick ratio of 4.29 and a debt-to-equity ratio of 0.62. First Advantage has a one year low of $12.46 and a one year high of $18.25. The business has a 50-day moving average price of $16.55 and a two-hundred day moving average price of $16.35.

First Advantage (NYSE:FA) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.21 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.21. The business had revenue of $184.55 million during the quarter, compared to analyst estimates of $184.66 million. First Advantage had a return on equity of 14.12% and a net margin of 4.28%. The firm’s revenue was down .4% on a year-over-year basis. During the same period in the previous year, the company earned $0.24 EPS. As a group, analysts predict that First Advantage will post 0.83 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director James Lindsey Clark sold 5,603 shares of the business’s stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $16.25, for a total transaction of $91,048.75. Following the sale, the director now directly owns 45,027 shares in the company, valued at $731,688.75. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 5.30% of the company’s stock.

Institutional Trading of First Advantage

Institutional investors and hedge funds have recently modified their holdings of the company. Quarry LP boosted its stake in First Advantage by 49.7% in the 2nd quarter. Quarry LP now owns 2,607 shares of the company’s stock valued at $42,000 after buying an additional 865 shares in the last quarter. Fred Alger Management LLC acquired a new stake in First Advantage in the 2nd quarter valued at $12,906,000. Marshall Wace LLP acquired a new stake in First Advantage in the 2nd quarter valued at $209,000. Sei Investments Co. boosted its stake in First Advantage by 27.5% in the 2nd quarter. Sei Investments Co. now owns 126,159 shares of the company’s stock valued at $2,027,000 after buying an additional 27,237 shares in the last quarter. Finally, Blair William & Co. IL acquired a new stake in First Advantage in the 2nd quarter valued at $297,000. 94.91% of the stock is currently owned by institutional investors.

First Advantage Company Profile

First Advantage Corporation provides employment background screening, identity, and verification solutions worldwide. It offers pre-onboarding products and solutions, such as criminal background checks, drug/health screening, extended workforce screening, FBI channeling, identity checks and biometric fraud mitigation tools, education/work history verification, driver records and compliance, healthcare credentials, executive screening, and other screening products.